loadpatents
name:-0.018579006195068
name:-0.021224975585938
name:-0.0015909671783447
Karmali; Rashida A. Patent Filings

Karmali; Rashida A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Karmali; Rashida A..The latest application filed is for "mehods and compositions for treating sars-cov-2 infection using carboxyamidotriazole orotate".

Company Profile
0.26.21
  • Karmali; Rashida A. - Brooklyn NY US
  • Karmali; Rashida A - Brooklyn NY
  • Karmali; Rashida A. - New York NY
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Mehods and Compositions for Treating SARS-CoV-2 Infection using Carboxyamidotriazole Orotate
App 20220168276 - Karmali; Rashida A.
2022-06-02
Methods and compositions for treating SARS-CoV-2 infection using carboxyamidotriazole orotate
Grant 11,318,118 - Karmali May 3, 2
2022-05-03
Methods and molecular pharmacodynamic biomarkers for multiple signaling pathways in response to carboxyamidotriazole orotate
Grant 10,378,059 - Karmali A
2019-08-13
Methods and Compositions for Treating Cancers having Acquired Resitance to prior Chemotherapeutic and Targeted Drugs Using Carboxyamidotriazole Orotate
App 20160367553 - Karmali; Rashida A.
2016-12-22
Compositions for treating cancers having acquired resitance to prior chemotherapeutic and targeted drugs using carboxyamidotriazole orotate
Grant 9,089,570 - Karmali July 28, 2
2015-07-28
Methods and Molecular Pharmacodynamic Biomarkers for Multiple Signaling Pathways in Response to Carboxyamidotriazole Orotate
App 20150038349 - Karmali; Rashida A.
2015-02-05
Compositions and processes for preparing 5-amino or substituted amino 1,2,3-triazoles and triazoles orotate formulations
Grant 8,912,223 - Karmali December 16, 2
2014-12-16
Methods and compositions for enhancing sensitivity of cytotoxic drugs with timely combinatorial therapy with carboxyamidotriazole orotate
Grant 8,877,785 - Karmali November 4, 2
2014-11-04
Methods and compositions for treating cancers having acquired resitance to prior chemotherapeutic and targeted drugs using carboxyamidotriazole orotate
App 20140294806 - Karmali; Rashida A.
2014-10-02
Compositions and methods of improving the tolerability of daunorubicin when given as orotate salt
Grant 8,802,831 - Karmali August 12, 2
2014-08-12
Novel compositions and processes for preparing 5-amino or substituted amino 1,2,3-triazoles and triazoles orotate formulations
App 20140200247 - Karmali; Rashida A.
2014-07-17
Use of Carboxyamidotriazole (CAI) orotate in macular degeneration
Grant 8,420,658 - Karmali April 16, 2
2013-04-16
Pharmaceutical compositions containing paclitaxel orotate
Grant 8,415,388 - Karmali April 9, 2
2013-04-09
Compositions and processes for preparing 5-amino or substituted amino 1,2,3-triazoles and triazole orotate formulations
Grant 8,377,973 - Karmali February 19, 2
2013-02-19
Methods and compositions for enhancing sensitivity of cytotoxic drugs with timely combinatorial therapy with carboxyamidotriazole orotate
App 20120202760 - Karmali; Rashida A.
2012-08-09
Compositions and methods of improving the tolerability of daunorubicin when given as orotate salt
App 20120202761 - Karmali; Rashida A.
2012-08-09
Pharmaceutical compositions containing paclitaxel orotate
App 20120197017 - Karmali; Rashida A.
2012-08-02
Method of reducing cardiac levels of doxorubicin when given as orotate salt
Grant 8,148,339 - Karmali April 3, 2
2012-04-03
Method of increasing drug oral bioavailability and compositions of less toxic orotate salts
Grant 8,034,823 - Karmali October 11, 2
2011-10-11
Novel compositions and processes for preparing 5-amino or substituted amino 1,2,3-triazoles and triazole orotate formulations
App 20110060142 - Karmali; Rashida A.
2011-03-10
Use of carboxyamidotriazole (CAI) orotate in macular degeneration
App 20100298363 - Karmali; Rashida A.
2010-11-25
Use of carboxiamidotriazole (CAI) orotate in macular degeneration
Grant 7,750,018 - Karmali July 6, 2
2010-07-06
Compositions and methods of reducing side effects and toxicity of methotrexate when given as orotate derivatives
Grant 7,601,834 - Karmali October 13, 2
2009-10-13
Compositions and methods of reducing tissue levels of drugs when given as orotate derivatives
App 20090131344 - Karmali; Rashida A.
2009-05-21
Compositions and methods of reducing tissue levels of drugs when given as orotate derivatives
Grant 7,470,672 - Karmali December 30, 2
2008-12-30
Use of carboxiamidotriazole (CAI) orotate in macular degeneration
App 20080139592 - Karmali; Rashida A.
2008-06-12
Specimen collecting, processing and analytical assembly
Grant 7,378,054 - Karmali May 27, 2
2008-05-27
Compositions and methods of reducing tissue levels of drugs when given as orotate derivatives
App 20080025949 - Karmali; Rashida A.
2008-01-31
Compositions and methods of reducing side effects and toxicity of methotrexate when given as orotate derivatives
App 20070179145 - Karmali; Rashida A.
2007-08-02
Method of increasing drug oral bioavailability and compositions of less toxic orotate salts
App 20060189640 - Karmali; Rashida A.
2006-08-24
Specimen collecting, processing and analytical assembly
App 20050232813 - Karmali, Rashida A.
2005-10-20
Salts of aminoimidazole carboxamide and 5 amino or substituted amino 1,2,3-triazole, induce apoptosis, inhibit DNA synthesis and control cyclooxygenase activity
Grant 6,239,137 - Karmali , et al. May 29, 2
2001-05-29
Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases
Grant 6,184,227 - Karmali February 6, 2
2001-02-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed